Summary
Updated Aug 30, 2026
Jeffrey Lawrence Schwartz files SEC Form 4 reports at KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). 1 SEC Form 4 filing on record, dated 4 September 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Jeffrey Lawrence Schwartz has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey Lawrence Schwartz files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Daniel Webster - $5.07M of KMTS open-market activity in the last 12 months
- Vaseem Mahboob - $1.27M of KMTS open-market activity in the last 12 months
- Alfred J. Ford Jr. - $1.13M of KMTS open-market activity in the last 12 months
- Traci S. Umberger - $1.11M of KMTS open-market activity in the last 12 months
- Raymond W. Cohen - $489K of KMTS open-market activity in the last 12 months
- Timothy P. Moran - $348K of KMTS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jeffrey Lawrence Schwartz?
Jeffrey Lawrence Schwartz is a corporate insider of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Jeffrey Lawrence Schwartz last file a Form 4?
The only primary Form 4 on record is dated 4 September 2025.
Where can I see all of Jeffrey Lawrence Schwartz's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jeffrey Lawrence Schwartz and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
